ProCE Banner Activity

A Focus on Menstrual-associated Migraine

Clinical Thought

It is well known that migraine affects women more often than men, likely due to hormone fluctuations observed with menses. Differentiating menstrual migraine from chronic or episodic migraine poses a challenge in diagnosis and treatment selection. In this ClinicalThought, diagnostic criteria for menstrual migraine—including “pure” menstrual migraine—and evidence-based treatment strategies are reviewed.

Released: April 14, 2022

Expiration: April 13, 2023

No longer available for credit.



Maureen Moriarty

Maureen Moriarty, DNP, ANP-BC

Associate Professor
Malek School of Nursing Professions
Marymount University
Arlington, Virginia
Moriarty Associates: A Comprehensive Headache Center
Westminster, Maryland


This activity is supported by educational funding provided by Amgen and AbbVie Inc.

Provided by

ProCE Banner

Target Audience

NPs and PAs


Dr Moriarty: consultant/advisor/speaker: AbbVie/Allergan, Amgen, Biohaven, Lilly; researcher: Teva.

Additional Information

Program Medium

This program has been made available online.